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Abstract
Background: Hepatitis B virus (HBV) is a major cause of liver infection in human. Because of the lack of an appropriate 
cell culture system for supporting HBV infection efficiently, the cellular and molecular mechanisms of hepadnavirus 
infection remain incompletely understood. Duck heptatitis B virus (DHBV) can naturally infect primary duck 
hepatocytes (PDHs) that provide valuable model systems for studying hepadnavirus infection in vitro. In this report, we 
explored global changes in cellular protein expression in DHBV infected PDHs by two-dimension gel electrophoresis 
(2-DE) combined with MALDI-TOF/TOF tandem mass spectrometry (MS/MS).
Results: The effects of hepadnavirus infection on hepatocytes were investigated in DHBV infected PDHs by the 2-DE 
analysis. Proteomic profile of PDHs infected with DHBV were analyzed at 24, 72 and 120 h post-infection by comparing 
with uninfected PDHs, and 75 differentially expressed protein spots were revealed by 2-DE analysis. Among the 
selected protein spots, 51 spots were identified corresponding to 42 proteins by MS/MS analysis; most of them were 
matched to orthologous proteins of Gallus gallus, Anas platyrhynchos or other avian species, including alpha-enolase, 
lamin A, aconitase 2, cofilin-2 and annexin A2, etc. The down-regulated expression of beta-actin and annexin A2 was 
confirmed by Western blot analysis, and potential roles of some differentially expressed proteins in the virus-infected 
cells have been discussed.
Conclusions: Differentially expressed proteins of DHBV infected PDHs revealed by 2-DE, are involved in carbohydrate 
metabolism, amino acid metabolism, stress responses and cytoskeleton processes etc, providing the insight to 
understanding of interactions between hepadnavirus and hepatocytes and molecular mechanisms of hepadnavirus 
pathogenesis.
Introduction
The HBV, prototype of the Hepadnaviridae family, is a
noncytopathic hepatotropic DNA virus replicating via
reverse transcription [1]. More than 350 million individu-
als are HBV carriers worldwide and over one-third of
them develop serious liver diseases such as chronic hepa-
titis, cirrhosis and primary hepatocellular carcinoma [2].
Major obstacles in HBV research have been the inability
of the virus to infect cells in vitro and lack of adequate
animal models for HBV infection, though primary human
hepatocytes and HepaRG cell line have been used to
study HBV infection [3]. Human primary hepatocytes
and HepaRG cells can support HBV life cycle, but have
limitations in accessibility, reproducibility and low level
of HBV replication, and a large amount of input virus was
needed to infect low proportion of cells [4-6]. DHBV and
woodchuck hepatitis B virus (WHBV) are classified into
the family of hepadnaviridae. Thus for hepadnavirus
infection primary hepatocytes of ducks (DHBV) and
woodchucks (WHBV) are still considered as suitable
models for investigating the viral replication and patho-
genesis [7,8].
The development of proteomic methods has enabled us
to investigate the changes of cellular protein expression at
a global scale to reveal virus-host interactions [9-12]. The
effect of hepadnavirus replication on the host cells, such
as the carcinoma derived hepatocyte lines transfected
with the HBV genome, HepaRG cell lines or HBV trans-
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[13-15]. In the present study, we intend to utilize the
DHBV-PDHs system to explore global protein expression
changes during hepadnavirus infection by 2-DE. A total
of 75 differentially expressed protein spots were revealed
by 2-DE between DHBV infected and uninfected PDHs,
and 51 protein spots have been identified by MS/MS
analysis. Differential expression of beta-actin and
annexin A2 was confirmed by Western blot analysis, and
potential roles of some differentially expressed proteins
in the viral infection have been discussed.
Results
DHBV infection of PDHs
PDHs isolated from the same liver of DHBV-negative
Cherry Valley duckling were infected with DHBV at mul-
tiplicity of infection of 30 (MOI, based on DHBV DNA
genome equivalents) and cultured for 12, 24, 72 and 120 h
in L15 medium supplemented with 5% fetal bovine serum
(FBS). The efficiency of DHBV infection in PDHs was
determined by indirect immunofluorescence using anti-
DHBV preS monoclonal antibody. PDHs inoculated with
phosphate-buffered saline (PBS, pH 7.2) as a control. At
12 h and 24 h after infection, only a few cells showed fluo-
rescence (data not shown), and at 72 h post-infection
about 30% of cells expressed viral large surface antigen,
indicating that cells were infected with DHBV, showed in
Figure 1. DHBV DNA in PDHs was analyzed by Southern
blot hybridization using an alpha-32P-dCTP labeled
DHBV-specific probe, and DHBV in the supernatant was
detected by real time polymerase chain reaction (PCR).
Single stranded forms of intracellular viral DNA and
DHBV copy number increasing in the supernatant indi-
cated the replication of DHBV 72 h and 120 h post-infec-
tion (Additional File 1 and 2).
2-DE analysis of differentially expressed proteins of DHBV 
infected PDHs
Differentially expressed proteins between DHBV infected
and uninfected PDHs at 24, 72 and 120 h post-infection
were analyzed using the 2-DE. The gels were stained by a
modified silver staining method compatible with mass
spectrometry (MS) analysis and processed for image
analysis. On the 2-DE gels (pH 3-10 NL, 24 cm), about
1150~1350 protein spots were detected. Compared with
the parallel uninfected PDHs, 91 differentially expressed
protein spots were revealed by 2-DE (p-values less than
0.05 with at least a 1.5-fold difference in percentage of the
volume), shown in Figure 2 and Additional File 3 (see also
Additional File 4), and a total of 75 differentially
expressed non-redundant protein spots were analyzed by
MS/MS.
Identification of differentially expressed proteins in DHBV 
infected PDHs
Differentially expressed protein spots between DHBV
infected and uninfected PDHs, were excised, digested in-
gel with trypsin and determined by MS/MS. Among 75
differentially expressed protein spots, 51 protein spots
were identified corresponding to 42 proteins (Table 1 and
Additional File 5). With a MASCOT cutoff score of 72 (p-
value less than 0.05), 51 spots were identified, and 37
spots were matched to orthologous proteins of avian spe-
cies (26 protein spots to Gallus gallus, 4 spots to Anas
platyrhynchos and 7 spots to other avian species), listed
in Table 1. Some of the differentially expressed protein
spots such as annexin A2, beta-actin, lamin A, destrin,
aconitase 2 and Mn superoxide dismutase were illus-
trated in enlarged formats (Figure 3), and representative
mass spectrum of annexin A2 (spot 49) analyzed by
MALDI-TOF/TOF MS was shown in Figure 4. Isoforms
of annexin A2, alpha-enolase, lamin A, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), heat shock protein
70 (Hsp70) and elongation factor 2 have been identified.
For example, protein spot 49 (MW 31 kDa and pI of 5.45)
and spot 50 (MW 10 kDa and pI of 5.78) down-regulated
in DHBV infected PDHs were both identified as annexin
A2, and up-regulated protein spot 26 (MW 65 kDa and pI
of 6.61) and spot 27 (MW 66 kDa and pI of 6.4) were
matched to lamin A (theoretical MW 73.1 kDa and pI of
6.5) showed in Figure 2.
Biological functions of the differentially expressed pro-
teins in the DHBV-infected PDHs, were analyzed accord-
ing to the Gene Ontology criteria and classified into
carbohydrate metabolism (29%), amino acid metabolism
(14%), cytoskeletal/structural protein (24%), stress
response (18%) and other functions (16%), as shown in
Table 1. The roles of selected differentially expressed pro-
teins reported in viral infections were showed in Table 2.
Validation of differentially expressed proteins
Expression levels of annexin A2, beta-actin, Hsp70,
destrin, and lamin A were validated by Western blot anal-
ysis to confirm the dynamic alterations of protein expres-
sion during DHBV infection. Equal amounts (30 μg) of
cell lysates of DHBV-infected and uninfected PDHs at 12,
24, 72 and 120 h post-infection were separated by SDS-
PAGE. Duck beta-actin and annexin A2 expression were
detected down-regulated in the DHBV-infected PDHs at
12-120 h post-infection with mouse anti-beta-actin and
anti-duck-annexin A2 as primary antibodies (Figure 5A),
that were consistent with the protein expression pattern
revealed by the 2-DE analysis. Duck Hsp70, destrin, and
lamin A were not detected by Western blot analysis with
the rabbit anti-human or anti-mouse Hsp70 polyclonal
antibodies, rabbit anti-human destrin polyclonal anti-
body and rabbit anti-human lamin A polyclonal antibody.
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a parallel SDS-PAGE gel and stained with Coomassie bril-
liant blue (Figure 5B).
Discussion
HBV infection remains a public health problem world-
wide. Because the lack of appropriate cell lines that can
support HBV infection efficiently, the cellular and molec-
ular mechanisms of hepadnavirus infection remain
incompletely understood. The hepadnavirus animal
infection models such as ducks (DHBV) and woodchucks
(WHBV) have been used to investigate the viral replica-
tion, pathogenesis or hepadnavirus-associated hepatocel-
lular carcinoma. DHBV-PDHs model is a valuable model
of hepadnavirus infection with high reproducibility and
efficiency [16]. In the present study, global changes in cel-
lular protein expression in DHBV-infected PDHs were
explored by 2-DE combined with MS/MS. Among the 75
differentially expressed protein spots, 51 spots have been
identified by MS/MS corresponding to 42 proteins, in
which 30 spots were matched to orthologous proteins of
Gallus gallus or Anas platyrhynchos, 7 spots to other
avian species, and 14 spots to non-avian species, while
mass spectra of the other 24 protein spots did not match
to any proteins in the current databases, possibly due to
the incomplete genome sequence of Anas platyrhynchos
or low abundance of those protein spots.
In previously studies, Tong performed a proteomic
analysis comparing HepG2 with HepG2.2.15 in which
HBV genome integrated into cellular chromosome [13],
and Narayan revealed 19 differentially regulated features
in HepaRG cells by 2-DE [14]. HepG2.2.15 is a HBV repli-
cation cell model but not an infection model, while the
human hepatoma HepaRG cells are susceptible to HBV,
but 10~20% of cells can be infected regardless of the
amount of virus used (MOI > 200) [4,6]. In previous stud-
ies, it has been showed that at MOI of 30, about 50%~60%
PDHs can be reproducibly infected with DHBV [17].
Some of differentially expressed proteins identified in the
present study, such as alpha-enolase, lamin A, GAPDH
and cofilin-2 have not yet been reported in hepadnavirus
proteomic analysis.
Viruses depend on host cell metabolism for their repli-
cation. Elucidation of the pathways/processes involving
Figure 1 Detection of DHBV infected PDHs by indirect immunofluorescence. PDHs were prepared by liver perfusion and seeded on glass cov-
erslips, and infected with DHBV concentrated from the supernatant of LMH-D2 by ultracentrifugation. PDHs were fixed with 4% polyoxymethylene. 
DHBV infected PDHs was detected by indirect immunofluorescence staining with mouse anti-DHBV preS mAb, and followed by goat anti-mouse IgG-
FITC antibody. Then cells were stained with DAPI and visualized by confocal microscopy (Green, FITC; blue, DAPI). The symbol "p.i." represents DHBV 
post-infection PDHs.
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nisms of viral infection. In the 2-DE analysis, the identi-
fied differentially expressed proteins were classified into
carbohydrate metabolism, amino acid metabolism,
cytoskeletal/structural protein, stress response and other
functions according to the Gene Ontology criteria. Some
of differentially expressed proteins identified in the pres-
ent study have been reported playing roles in viral infec-
tions, as shown in Table 2.
In DHBV infected PDHs, the expression of some carbo-
hydrate metabolic enzymes, such as phosphoglycerate
kinase 1, triosephosphate isomerase, phosphoglycerate
mutase 1 etc, was up-regulated. The differentially
expressed proteins involving in carbohydrate metabo-
lism, suggests perturbed energy metabolism in DHBV
infections. Hepatitis C Virus (HCV) infection reprograms
the cellular metabolisms to favor glucose fermentation
and glycolytic intermediates toward the metabolite syn-
thesis that supports the viral life cycle [18]. In lympho-
cytic choriomeningitis virus infection, there was a
significant increasing in transcripts promoting gluconeo-
genesis for viral mediate synthesis, and a decreasing in
transcripts promoting glycogenolysis in the early stage of
infection [19].
However, GAPDH and alpha-enolase, key enzymes
involving in glycolysis and gluconeogenesis, are
decreased in DHBV infected PDHs. GAPDH and alpha-
enolase have been found associating with the cell mem-
brane and in secreted viral particles of influenza virus,
lentiviral vector etc [20,21]. GAPDH may phosphorylate
the HBV core protein, and binds to the preS1 region of
the HBV envelope antigen and posttranscriptional regu-
latory element in regulating expression of surface antigen,
suggesting that GAPDH plays an important role in the
life-cycle of HBV infection [22-24]. The host cellular car-
bohydrate metabolism affected by DHBV infection may
benefit viral replication.
Alterations of cytoskeleton networks were found in
many viral infections [25-27]. Hepadnavirus needs to
manipulate and utilize the host cytoskeleton to promote
viral infection like many viruses, although the mechanism
is still unclear [28]. In DHBV infected PDHs, the microfil-
ament-associated proteins, beta-actin and cofilin-2 were
down-regulated, and three microfilament-associated pro-
teins such as transgelin, destrin, and collapsin response
mediator protein-2B were up-regulated. Actin plays an
active role in maturation of the viruses [29,30]. Many
viruses require actin for viral entry and establishment of
Figure 2 Comparison of 2-DE gel patterns between DHBV infected and uninfected PDHs. Proteins were extracted from DHBV infected and un-
infected PDHs at 24, 72 and 120 h post-infection. Equal proteins (120 μg) were loaded and separated on the 24-cm pH 3-10 nonlinear IPG strips, fol-
lowed by 12% SDS-PAGE gels visualized by silver staining. Differentially expressed protein spots on 2-DE gels were identified by MS/MS analysis and 
shown in gels with unique protein spot numbers. Gels of B, D, F and A, C, E represent 2-DE gels obtained from DHBV infected and uninfected PDHs at 
24, 72 and 120 h post-infection, respectively. The numbers of unidentified spots are underlined and listed in Additional File 4, the numbers of up-
regulated protein spots in infected samples are labeled in red and the numbers of down-regulated protein spots in blue color (A~F).
/Emwd TpI/EpIe Ratio: infected/uninfected
24h 72h 120h
6.6/29 6.71/6.62 1.5 1 Nf
2.5/16 6.19/6.00 1.4 3 1
5.7/22 8.71/7.41 1 0.5 N
5.7/13 8.71/6.23 0.66 0.2 N
4.8/25 8.71/7.80 1 0.5 N
5.7/12 8.71/5.79 1 1 0.2
4.7/42 8.31/5.66 2.5 1.5 1
8.9/25 7.03/7.39 1.5 1.3 1
0.8/32 6.28/5.45 0.66 0.8 0.5
7.2/43 6.37/6.12 0.25 N N
.7/103 8.05/7.78 N 2 1.8
1.5/23 6.4/5.85 1.2 0.9 2.3
9.8/24 9.13/6.47 1.3 0.56 1
1.5/27 6.07/6.00 0.17 N 1
2.7/24 6.58/5.45 1 1.2 0.5
5.8/28 6.84/6.80 1.5 1 1





































Table 1: Differentially expressed proteins in DHBV-infected PDHs identified by MALDI-TOF/TOF
Spot No.a Protein Species Accession No.b MOWSE Scorec Tmw
Carbohydrate metabolism
1 Triosephosphate isomerase 1 Gallus gallus gi|45382061 385 2
2 Triosephosphate isomerase Meleagris gallopavo gi|34221747 99 2
3 Glyceraldehyde-3-phosphate 
dehydrogenase(GAPDH)
Columba livia gi|6016077 109 3
4 Glyceraldehyde-3-phosphate 
dehydrogenase(GAPDH)
Columba livia gi|6016077 102 3
5 Glyceraldehyde-3-phosphate 
dehydrogenase(GAPDH)
Passer domesticus gi|37698402 131 3
6 Glyceraldehyde-3-phosphate 
dehydrogenase(GAPDH)
Columba livia gi|6016077 94 3
7 Phosphoglycerate kinase 1 Gallus gallus gi|45384486 231 4
8 Phosphoglycerate mutase 1 Gallus gallus gi|71895985 135 2
9 Alpha-enolase Anas platyrhynchos gi|213085 124 4
10 Alpha-enolase Anas platyrhynchos gi|119338 340 4
11 Aconitase 2, mitochondrial Gallus gallus gi|45383738 227 85
12 ATP5A1 Taeniopygia guttata gi|91805309 380 2
13 Atp5a1 protein Xenopus tropicalis gi|71896075 146 5
14 Chain E, Chicken Cytochrome Bc1 Complex 
Inhibited By An Iodinated Analogue Of The 
Polyketide Crocacin-D
Xenopus tropicalis gi|196049779 146 2
15 similar to ubiquinol--cytochrome c 
reductase
Gallus gallus gi|50754375 72 5
Amino acid metabolism
16 unnamed protein product Mus musculus gi|74183518 118 3










18 Pterin-4 alpha-carbinolamine dehydratase Gallus gallus gi|45382483 170 12.0/11 6.04/5.42 1 1.8 N
.1/149 7.21/6.12 1 0.5 1.2
.1/149 7.21/5.91 1 0.66 1.7
3.2/32 5.66/5.80 0.75 0.25 N
1.7/58 8.22/7.18 N 3 1.2
2.3/19 8.85/7.78 1 3 1.4
6.9/116 6/6.12 N 3 1
8.5/18 7.52/6.60 1.5 1.33 2
3.1/65 6.5/6.61 N 2 2
3.1/66 6.5/6.40 N 1.5 2
0.5/15 4.62/3.80 1 1 A/Ng
0.9/11 6.58/5.79 0.5 1 0.33
2.2/69 6.05/6.12 N A/N 2
8.6/14 7.66/5.20 0.33 1.2 0.67
5.8/14 5.93/6.19 N 0.25 1
5.1/37 6.2/6.61 N/Ag 1.3 1
1.7/41 5.16/5.40 0.63 0.8 0.94
3.5/20 5.59/7.80 N N A/N
1.9/29 6.63/5.72 0.7 0.33 1
2/96 5.12/5.00 N A/N 1
2/96 5.12/5.00 N A/N 1
7.6/65 6.36/6.60 1 2 1.3





































19 similar to Urocanase domain containing 1 Gallus gallus gi|50754419 127 75
20 similar to Urocanase domain containing 1 Gallus gallus gi|50754419 99 75
21 similar to 3-mercaptopyruvate 
sulfurtransferase
Gallus gallus gi|50794693 144 3
22 Aldehyde dehydrogenase 4A1 Xenopus laevis gi|148228402 99 6
Cytoskeletal/structural protein
23 Transgelin Gallus gallus gi|45382783 92 2
24 Vinculin Gallus gallus gi|45382123 82 11
25 Destrin Gallus gallus gi|45382979 97 1
26 Lamin A Gallus gallus gi|45384214 168 7
27 Lamin A Gallus gallus gi|45384214 74 7
28 similar to Myosin regulatory light chain 
2,nonsarcomeric (Myosin RLC) isoform 1
Canis lupus familiaris gi|73961895 241 2
29 similar to HSPC162(dynein, light chain) Gallus gallus gi|50758587 86 1
30 Collapsin response mediator protein-2B Gallus gallus gi|33340025 173 6
31 Cofilin-2 Gallus gallus gi|17433708 74 1
32 Gelsolin Gallus gallus gi|45384386 95 8
33 similar to LIM protein Danio rerio gi|68371150 84 3
34 beta-actin Labeo calbasu gi|18034011 343 4
Stress response
35 similar to heat shock 70kDa protein 8 
isoform 2 isoform 2
Canis lupus familiaris gi|74012289 74 5
36 Chain A, T13g Mutant Of The ATPase 
Fragment Of Bovine Hsc70
Bos taurus gi|6729825 237 4
37 Heat shock 70kDa protein 5 precursor Gallus gallus gi|45382769 526 7
38 Heat shock 70kDa protein 5 precursor Gallus gallus gi|45382769 471 7
39 Chaperonin containing TCP1, subunit 6A 
(zeta 1)
Gallus gallus gi|57525300 211 5
40 58kDa glucose regulated protein precursor Gallus gallus gi|45383890 251 5











41 Mn superoxide dismutase Cairina moschata gi|184133036 235 12.9/24 6.39/7.00 1 1 1.71
6.6/25 6.79/6.80 1.5 1.43 1.5
9.9/28 6.07/5.70 1 1 0.5
5.1/16 5.83/5.85 1 0.66 0.67
9.9/15 6.2/5.78 1 1 0.5
7.6/25 5.74/5.08 1 1 1.5
5.2/28 5.83/5.45 N 0.29 0.85
5.6/91 6.19/6.60 N 1.5 1.3
8.6/31 6.92/5.45 0.33 1 0.5
8.6/10 6.92/5.78 0.5 N 0.2
4.9/12 5.28/5.00 0.5 1 0.86





































42 similar to antioxidant protein isoform 2 
(peroxiredoxin-3)
Sus scrofa gi|194042134 256 2
43 LOC496089 protein Xenopus laevis gi|56269242 97 2
Other functions
44 Elongation factor 2 Oxyuranus scutellatus gi|63146080 83 4
45 Elongation factor 2 Mus musculus gi|192989 140 2
46 Cathepsin B Gallus gallus gi|46195455 73 3
47 ubiquitin carboxyl-terminal esterase L1 
(ubiquitin thiolesterase)
Taeniopygia guttata gi|115391986 132 2
48 Ovotransferrin Anas platyrhynchos gi|3024757 144 7
49 Annexin A2 Gallus gallus gi|45382533 148 3
50 Annexin A2 Gallus gallus gi|45382533 204 3
51 Annexin A5 Anoplopoma fimbria gi|229366222 75 3
a) Spots numbers correspond to the numbers in Figure 2.
b) Accession no. is the MASCOT result of MALDI-TOF/TOF searched from the NCBInr database.
c) Protein score was from MALDI-TOF/TOF identification. The proteins that had a statistically significant score great than 72 (p < 0.05) we
d) Theoretical/experimental molecular mass.
e) Theoretical/experimental molecular pI.
f) Not applicable, because the spots on the gels were too weak or non-detectable.
g) A represents the spot on one of the gels was detectable, N represents the spot on one of the gels was too weak to detect.
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(HIV), adenovirus, Simian virus 40, and vaccinia virus
[31-34]. However, the actin cortex beneath the plasma
membrane can also be an obstacle for virus entry or bud-
ding [35]. It has been reported that DHBV entry depends
on both intact microtubules and their dynamic turnover
but not actin cytoskeleton [28]. Therefore the role of
actin in DHBV replication is required to further investi-
gation.
Lamin A is key structural components of the nuclear
lamina and lamins, involving in DNA replication and
gene expression, as well as presenting a natural barrier
against most DNA viruses such as human cytomegalovi-
rus (HCMV), Kaposi's sarcoma-associated herpesvirus,
herpes simplex virus (HSV) 1 and Epstein-Barr virus [36].
Lamin A/C is phosphorylated in HSV-infected cells sup-
porting a role in regulating virus capsid nuclear egress
[37,38]. Infection of Epstein-Barr virus induced disassem-
bly of the nuclear lamina and redistribution of nuclear
lamin for the nuclear egress [39]. The expression of lamin
A with different isoforms, were up-regulated in DHBV
infected PDHs, suggesting that lamin A may play a role in
DHBV replication.
In DHBV infected PDHs, up-regulated expressions of
amino acid metabolism enzymes, catalyzing interconver-
sion of glutamate, histidine, and proline (Glutamate
dehydrogenase 1, Urocanate hydratase, Delta-1-pyrro-
line-5-carboxylate dehydrogenase, the orthologs in
human referred to protein 16, 19 and 20, 22 in Table 1),
indicate that glutamine metabolism is enhanced. Switch-
Figure 3 The enlarged 2-DE profiles of the differentially expressed proteins in the PDHs. The enlarged images of annexin A2, beta-actin, lamin 
A, destrin, Aconitase 2 and Mn superoxide dismutase protein spots are shown. Arrows indicate the differentially expressed proteins in 2-DE gels be-
tween DHBV infected and uninfected PDHs at 24, 72, and 120 h post-infection.
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accommodate the biosynthetic and energetic needs of the
viral infection and to allow glucose to be used biosynthet-
ically was reported in HCMV infection [40]. HCV-
infected cells exhibit increased levels of the enzymes cat-
alyzing glutamine flux to replenish metabolic intermedi-
ates through the latter half of the citric acid cycle
providing substrates for ATP production [18]. Thus simi-
lar mechanism of glutamine metabolism may be at work
in DHBV infection.
Stress response associated proteins including endoplas-
mic reticulum stress associated proteins such as Hsp70,
and chaperonin containing t-complex polypeptide 1
(TCP1) and oxidative stress associated proteins such as
antioxidant enzymes Mn superoxide dismutase and per-
oxiredoxin-3 (similar to antioxidant protein isoform 2)
were found to be up-regulated post DHBV infection.
Figure 4 Representative mass spectra of annexin A2 analyzed by MALDI-TOF/TOF MS. The differentially expressed protein spot 49 was in-gel 
digested by trypsin, and peptide mixture was analyzed by MALDI-TOF/TOF Proteomics Analyzer. (A) MS spectrum with tryptic peptides of annexin A2, 
(B) MS/MS spectrum of the precursor ion with m/z 1111.67 marked in A for peptide QDIAFAYQR of annexin A2; fragments observed in the spectrum 

















































Table 2: The roles of differentially expressed proteins reported in viral infections
Protein Name Functions indicated in viral infections References
Aconitase 2, mitochondrial Binding to the 3'-untranslated region of the mouse hepatitis virus genome and 
increasing virus production as well as viral protein synthesis at early hours of 
infection
Nanda et al., 2001. J Virol. 75, 3352-62.
Phosphoglycerate kinase 1 Regulating Sendai virus transcription through their interactions with tubulin Ogino et al., 2001. Biochem Biophys Res Commun. 285, 447-55.
Triosephosphate isomerase Increased between cancerous and noncancerous tissues from hepatocellular 
carcinoma patients
Kuramitsu et al., 2005. Expert Rev Proteomics. 2, 589-601.
Phosphoglycerate mutase 1 Specifically binding to the core region of HCV RNA genome in vitro Su et al., 2007. Intervirology. 50, 303-9.
Alpha-enolase A candidate biomarker for HCV-related hepatocellular carcinoma; required for 
efficient transcription of Sendai virus genome
Takashima et al., 2005. Proteomics. 5, 1686-92.
Ogino et al., 2001. Biochem Biophys Res Commun. 285, 447-55.
GAPDH May interfere in the life-cycle of HBV to phosphorylate HBV core protein and playing 
roles in HBV infection in intracellular processes
Duclos-Vallee et al., 1998. J Gen Virol. 79 (Pt 7), 1665-70.
Duclos-Vallee et al., 2002. Hepatol Res. 22, 65-73.
Lamin A Impeding HSV-1 infectivity; Phosphorylated in HSV-infected cells, regulating virus 
capsid nuclear egress; Epstein-Barr virus reactivation-mediated redistribution of 
nuclear lamin to modulate the cellular environment for virion production; 
cytomegalovirus induced distortion of the nuclear lamina
Mou et al., 2008. J Virol. 82, 8094-104.
Mou et al., 2007. J Virol. 81, 6459-70.
Lee et al., 2008. J Virol. 82, 11913-26.
Milbradt et al., 2007. J Gen Virol. 88, 2642-50.
Beta-actin Actin rearrangements contribute to Simian virus 40 endocytosis; required by viral 
particle up-taking and infection establishment, including HIV, adenovirus, Simian 
virus 40, and vaccinia virus, etc
Pelkmans et al., 2002. Science. 296, 535-9.
Pollard et al., 2003. Cell. 112, 453-65.
Bukrinskaya et al., 1998. J Exp Med. 188, 2113-25.
Li et al., 1998. J Virol. 72, 8806-12.
Ploubidou et al., 2001. Curr Opin Cell Biol. 13, 97-105.
Dynein, light chain Regulating Gag and viral RNA egress on endosomal membranes in the cytoplasm to 
directly impact on viral production; microtubule-dependent dynein activity 
increased through activation of the p38 MAPK by HBx, perhaps facilitating the 
process of maturation; directly used by poliovirus for retrograde axonal transport
Lehmann et al., 2009. J Biol Chem. 284, 14572-85.
Kim et al., 2007. J Virol. 81, 1714-26.
Gonzalez et al., 2007. Intervirology. 50, 214-8.
Cofilin-2 Possible involving in the process of HIV initial binding and fusion steps, and 
inhibiting some subsequent early post-entry events in HIV infection of T cells
Liu et al., 2009. Sci Signal. 2, pe23.
Heat shock protein 70B HBV P protein activation in vitro is fundamentally dependent on Hsc70/Hsp40; 
involving in HBV morphogenesis as a chaperone
Beck et al., 2003. J Biol Chem. 278, 36128-38.
Prange et al., 1999. Biol Chem. 380, 305-14.
Annexin A2 Assisting in the assembly of HIV, and supporting HIV-1 infection as a cellular 
cofactor; enhancing cytomegalovirus binding and membrane fusion and 
supporting the replication of influenza viruses by mediating activation of 
plasminogen
Ma et al., 2004. J Exp Med. 200, 1337-46.
Raynor et al., 1999. Biochemistry. 38, 5089-95.
LeBouder et al., 2008. J Virol. 82, 6820-8.
Elongation factor 2 Interacting with hepatitis B virus core protein in leukocytes; possessing a highly 
conserved anti-apoptotic activity induced by HIV-1 viral protein R
Lin et al., 2006. World J Gastroenterol. 12, 1043-8.
Zelivianski et al., 2006. Apoptosis. 11, 377-88.
Ovotransferrin Playing a crucial role in protecting the whole chicken embryo fibroblasts from 
Marek's disease virus infection spreading
Giansanti et al., 2007. Biochem Cell Biol. 85, 150-5.
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Page 11 of 16Hsp70 assists folding of many newly synthesized poly-
peptides, and refolding of the proteins misfolded [41,42].
Hsp70 can enhance flock house virus replication [43,44].
Hsp70 and Hsp90 participate in dengue virus entry as a
receptor complex [45]. Moreover, HBV P protein activa-
tion in vitro is fundamentally dependent on heat shock
protein 70 family Hsc70/Hsp40 [46]. In HBV-replicating
HepAD38 cell, expressions of heat shock proteins (Hsp70
and Hsp90) and Mn superoxide dismutase increase, after
HBV replication induced by tetracycline [47]. In human-
ized transgenic mice, inhibition of HBV replication
results in suppression of Mn superoxide dismutase
expression in hepatocytes [47,48]. It suggests that oxida-
tive stress can be induced by hepadnavirus replication as
Epstein-Barr virus [49].
Annexin A2, belongs to a family of calcium-dependent,
phospholipid binding proteins, is involved in many bio-
logical processes, such as the Ca2+ dependent exocytosis,
calcium transport and cell proliferation. It participates in
viral infection, including assisting in the assembly of HIV
in monocyte-derived macrophages [50], as a cellular
cofactor supporting HIV-1 infection [51], enhancing
cytomegalovirus binding and membrane fusion [52] and
supporting the replication of influenza viruses by mediat-
ing activation of plasminogen [53]. It has been reported
that HBV polymerase activity was inhibited by interacted
with S100A10, a protein binding to annexin A2 [54]. In
HepG2.2.15 compared with HepG2, annexin A2 was
revealed down-regulated [55], which was consistent with
our observation in DHBV-PDHs model and confirmed by
Western blot analysis. It indicated that annexin A2 may
involve in hepadnavirus infection and warrants further
investigation.
Beta-actin and GAPDH are usually referred as the
internal standards for detections of RNA transcription
and protein expression of genes. However, those proteins
were found to be down-regulated post DHBV infection
by 2-DE analysis. Recently, accumulated evidence showed
that in HBV-related hepatocellular carcinoma or viral
infections, beta-actin and GAPDH are unsuitable con-
trols in quantitative mRNA expression or Western blot
analysis due to variations in expression [56-60], though
there are controversial observations [61]. These findings
therefore highlight the importance of re-evaluating the
housekeeping genes whose expressions may be affected
by hepadnavirus infection.
Conclusions
In summary, the present study explored global changes in
cellular protein expression of hepadnavirus infection by
2-DE analysis, using a natural DHBV-PDHs infection sys-
tem. Forty-two differentially expressed proteins in DHBV
infected PDHs have been identified by MS/MS. Most of
them involve in carbohydrate metabolism, amino acid
metabolism, stress responses and cytoskeleton processes
including alpha-enolase, beta-actin, lamin A and annexin
A2. It suggests that those proteins may play important
roles in hepadnavirus infection. Differential expressions
of annexin A2 and beta-actin were confirmed by Western
blot analysis. Further investigation of the roles of the dif-
ferentially expressed cellular proteins will help to under-




Cherry Valley ducks (Anas platyrhynchos) were pur-
chased from Breeding Center of Shanghai Institute of
Veterinary Medical Sciences, China. Animal protocols
were approved by the Ethics Committee of Fudan Univer-
sity. Three-day-old ducklings with no congenital DHBV
infection detected by PCR (sence: 5'-CTCACTTTGTG-
GATCTCATTG-3', antisense: 5'-ATCGGATAGTCG-
GGTTGG-3'), were used for PDHs cultures. Duck
hepatocytes were isolated with in situ liver perfusion
method with modifications. After the duck was anesthe-
tized with approximately 0.3 ml of 0.75% pentobarbital
Figure 5 Confirmation of the differentially expressed proteins of 
annexin A2 and beta-actin by Western blot. The equal cell lysates of 
control and DHBV infected PDHs at 12, 24, 72 and 120 h post-infection 
were separated by SDS-PAGE, and detected by Western blotting with 
mouse anti-beta-actin and anti-duck annexin A2 as primary antibodies 
and then followed by horseradish peroxidase-conjugated goat anti-
mouse IgG as secondary antibody (A). The same amount protein of 
each sample were applied to a parallel SDS-PAGE gel and stained with 
Coomassie brilliant blue (B).
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Page 12 of 16sodium, the liver was perfused via portal vein with pre-
warmed liver perfusion medium (Gibco Laboratories),
then the inferior vena cava was cut to effuse the buffer
liquid when the liver was engorged. At first, perfusion
was maintained at 15 to 20 ml per minute with 100 ml of
liver perfusion medium until the liver became blanch,
then the liver became soft followed by 50 ml digestion
buffer with 1 μg/ml of collagenase type IV (Sigma) in L15
medium (Gibco). After the perfusion, the gallbladder was
removed and hepatocytes were dispersed in L-15
medium. Hepatocytes were filtered through sterilized
gauze, centrifuged at 40 g for 4 min, and washed three
times with Hepatocyte Wash Medium (Gibco). Then 4 ×
106 hepatocytes were seeded onto 100-mm-diameter dish
and incubated in L-15 medium containing 5% FBS (Gibco
Laboratories), 15 mM HEPES, 100 U penicillin per liter,
100 mg of streptomycin per liter, 1 mg of insulin (Sigma)
per liter and 10-5 M hydrocortisone-hemisuccinate
(Sigma) at 37°C. The medium was changed every day.
DHBV infection of PDHs
Infectious DHBV were produced by LMH-D2 cell line
which carries a stably integrated DHBV dimer and con-
stitutively secretes DHBV virions (generous gift of Wil-
liam Mason, Fox Chase Cancer Center, USA) [62]. DHBV
particles were obtained from LMH-D2 cells by ultracen-
trifugation, and the virus pellet was suspended in PBS
with 10% glycerol. DHBV was quantified using real time
PCR as a titer of 2 × 109 copies per milliliter. PDHs cul-
tured 16 h after plating were infected with purified
DHBV viral particles at MOI of 30, and incubated at 37°C
overnight. Then, they were washed with PBS three times
and cultured for 12, 24, 72 and 120 h in L15 medium sup-
plemented with 5% FBS.
Detection of DHBV infected PDHs
The efficiency of DHBV infection in PDHs was deter-
mined by indirect immunofluorescence and Southern
blot hybridization. Monolayers of PDHs grown on glass
coverslips were fixed directly by adding 4% polyoxymeth-
ylene at room temperature for 20 min, washed twice with
PBS and preincubated with 3% bovine serum albumin for
30 min. After incubation with a 1:100 dilution of mono-
clonal mouse anti-DHBV preS (generous gift of John C.
Pugh and William Mason, Fox Chase Cancer Center,
USA) at 37°C for 60 min, the cells were washed three
times with PBS, subsequently incubated with a 1:200
dilution of FITC-conjugated sheep anti-mouse IgG
(GGHL-90F, Immunology Consultants Laboratory) at
37°C for 30 min. Cell nucleus were stained with 1 μg/ml
4',6'-diamidino-2-phenylindole (DAPI, Sigma) and
mounted in 50% glycerol in PBS. Efficiency of DHBV
infection was observed by the confocal laser scanning
microscope (Leica). To detect DHBV replication, intrac-
ellular DNA was extracted from DHBV infected or unin-
fected PDHs. Forty micrograms of DNA from each
sample was separated on a 1.5% agarose gel, and analyzed
by Southern blot hybridization with an alpha-32P-dCTP
labeled DHBV-specific probe for detection as described
previously [63].
PDHs' protein sample preparation for 2-DE
The DHBV-infected and control (uninfected) PDHs at 24,
72, and 120 h post-infection were washed three times
with ice-cold PBS before harvesting and stored at -80°C.
PDHs for DHBV infection or the uninfected controls
were from the same duck in order to avoid individual dif-
ferences. Approximately 2 × 107 cells were lysed in 1 ml
lysis buffer (7 M urea, 2 M Thiourea, 2% (w/v) CHAPS,
50 mM dithiothreitol (DTT), 2% (v/v) pH 3-10 nonlinear
immobilized pH gradient (IPG) buffer (Amersham Bio-
sciences) containing 1% protease inhibitor cocktail
(Roche) and 1 mM PMSF (Sigma)), then sonicated on ice
for 12 cycles, each consisting of 5 s pulse and 10 s pause.
After centrifugation at 20,000 g at 4°C for 1 h, the super-
natants of lysates were divided into aliquots and the pro-
tein concentrations were determined by the Bradford
assay. Then, aliquots were stored at -80°C for further
analysis.
Two-dimensional gel electrophoresis and image analysis
The 2-DE gels were performed using 24-cm IPG strips
(pH 3-10, nonlinear, GE Healthcare) in Ettan IPGphor
Isoelectric Focusing System (Amersham Biosciences)
plus Ettan-Dalt six system (Amersham Biosciences)
according to the manufacturer's instructions. To com-
pensate the variability of gel electrophoresis, at least three
replicate gels were performed for each group. In the first
dimensional isoelectric focusing (IEF), 120 μg proteins of
each sample were diluted to 450 μl with rehydration buf-
fer containing 8 M urea, 2% (w/v) CHAPS, 50 mM DTT,
0.5% (v/v) ampholyte (pH 3-10, nonlinear, Amersham
Biosciences), and IPG strips were allowed to rehydrate in
the above solution under mineral oil. IEF was performed
as follow: 30 V for 6 h (active rehydration); 60 V for 6 h
(active rehydration); 500 V for 2 h, rapid; 1,000 V for 2 h,
rapid; 4,000 V for 2 h, linear; linear ramping to 8,000 V for
2 h, and finally 8,000 V for about 7 h with a total of 64
KVh at 20°C. Then the IPG strips were incubated in
equilibration buffer (75 mM Tris-HCl (pH 8.8), 6 M urea,
29.3% (v/v) glycerol, 2% (w/v) SDS and 0.002% (w/v) bro-
mophenol blue) containing 2% (w/v) DTT for 15 min
with gentle agitation, followed by incubation in the same
equilibration buffer supplemented with 2.5% (w/v) iodo-
acetamide for 15 min at room temperature. The second
dimension SDS-PAGE was performed on 1 mm thick
12.5% polyacrilamide vertical gels in Ettan-Dalt Six sys-
tem using 5 W/gel for 30 min, and followed by 12 W/gel
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Page 13 of 16at 10°C until the bromophenol blue dye front reached the
end of the gels. The gels were stained by a modified silver
staining method compatible with MS analysis [64] and
scanned at 300 dpi (dots/inch) using ImageScanner
(UMAX, Amersham Biosciences).
Images were captured and analyzed by ImageMaster
2D platinum 6.0 software (Amersham Biosciences). The
percentage of the volume of the spots representing a cer-
tain protein was determined in comparison with the total
proteins present in the 2-DE gel. To select differentially
expressed protein spots, quantitative analysis was per-
formed using the Student's t-test to compare the percent-
age volumes of spots between DHBV infected and
uninfected groups at three time points. The differentially
expressed protein spots with p-values less than 0.05 were
considered as significant differences, and at least 1.5 fold
difference in percentage of the volume for each spot was
set as a threshold. These protein spots were selected and
subjected to in-gel tryptic digestion and identification by
MS.
In-gel tryptic digestion
The differentially expressed protein spots were manually
excised from the sliver-stained gels (each gel of 120 μg
protein) and placed into a 96-well microplate. The gel
pieces were destained with a solution of 15 mM potas-
sium ferricyanide and 50 mM sodium thiosulfate (1:1) at
room temperature for 10 min, then washed twice with
deionized water, each for 30 min, and dehydrated in 80 μl
of acetonitrile (ACN) twice. Then the samples were swol-
len in a digestion buffer containing 25 mM NH4HCO3
and 12.5 ng/μl trypsin (Promega) at 4°C after 30 min
incubation, and incubated at 37°C for more than 12 h.
The peptide mixtures from the gel were extracted twice
using 0.1% trifluoroacetic/50% ACN at room tempera-
ture, re-suspended with 0.7 μl matrix solution (α-cyano-
4-hydroxy-cinnamic acid (Sigma) in 0.1% trifluoroacetic,
50% ACN), allowed to dry in air under the protection of
N2.
Mass spectrometric analysis and database searching
The peptide mixtures from samples were analyzed by
4700 MALDI-TOF/TOF Proteomics Analyzer (Applied
Biosystems). The UV laser was operated at a 200 Hz repe-
tition rate with wavelength of 355 nm. The accelerated
voltage was operated at 20 kV. Myoglobin digested by
trypsin was used to calibrate the mass instrument with
internal calibration mode. All acquired spectra of samples
were processed using 4700 series Explore software
(Applied Biosystems) in a default mode. The parent mass
peaks with mass range 700-3200 Da and minimum S/N
20 were picked out for tandem TOF/TOF analysis. Com-
bined MS and MS/MS spectra were submitted to MAS-
COT (V2.1, Matrix Science) by GPS Explorer software
(V3.6, Applied Biosystems) and searched with the follow-
ing parameters: NCBInr database (release date: 2009.11),
taxonomy of bony vertebrates or viruses, trypsin digest
with one missing cleavage, none fixed modifications, MS
tolerance of 100 ppm, MS/MS tolerance of 0.6 Da and
possible oxidation of methionine. Known contaminant
ions (human keratin and tryptic autodigest peptides, etc.)
were excluded. MASCOT protein scores (based on MS
and MS/MS spectra) with greater than 72 were consid-
ered statistically significant (p < 0.05). The individual
MS/MS spectrum with statistically significant (confi-
dence interval >95%) and best ion score (based on MS/
MS spectra) was accepted. To eliminate the redundancy
of proteins that appeared in the database under different
names and accession numbers, the protein belonging to
the species Anas platyrhynchos or with the highest pro-
tein score (top rank) was singled out.
Preparation of polyclonal mouse anti-annexin A2
Duck cDNA of annexin A2 was amplified by reverse tran-
scription-PCR with the primers designed according to
the sequence of the chicken annexin A2 (GenBank Acces-
sion No. gi|45382533, sense: 5'-CCGCTCGAGGTC-
CTCTCCACCACACAGGT-3' and antisense: 5'-CCG
CTCGAGGTCCTCTCCACCACACAGGT-3'). The full-
length of duck annexin A2 amplified from PDHs, was
cloned into prokaryotic expression plasmid pET-28a
(Novagen). Recombinant annexin A2 with C-terminal
fusion His-tag was induced by IPTG, and purified by Ni-
NTA affinity chromatography (QIAGEN). BALB/c mice
were immunized by the purified recombinant duck
annexin A2 with Freund's complete adjuvant (Sigma).
The serum was collected 2 weeks following the final
injection and the levels of anti-duck-annexin A2 antibody
titers from immunized mice were determined by Western
blot.
Western blot analysis of differential proteins
Differential expression of duck beta-actin, annexin A2,
Hsp70, destrin and lamin A were confirmed by Western
blot analysis. The primary antibodies for detection were
as follow: a monoclonal antibody against beta-actin
(Sigma), rabbit anti-human lamin A polyclonal antibody
(Santa Cruz Biotechnology and Proteintech), rabbit anti-
human Hsp70 polyclonal antibody (Santa Cruz Biotech-
nology), rabbit Hsp70 polyclonal antibody (BIOS), rabbit
anti-human destrin polyclonal antibody (PROTEIN-
TECK) and mouse anti-duck-annexin A2 polyclonal anti-
body prepared in our laboratory described as above.
Thirty microgram proteins from each sample were sepa-
rated in 12% SDS-PAGE gels and transferred to PVDF
membranes using the transfer system (BioRad). The blots
were blocked with 5% nonfat milk for 2 h at room tem-
perature and incubated at 4°C overnight with 1:200-1:500
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Page 14 of 16dilution of primary antibody. The blots were then washed
four times with PBS containing 0.1% Tween-20, and incu-
bated with the appropriate horseradish peroxidase-conju-
gated secondary antibody (Santa Cruz Biotechnology) 1
hour at room temperature. After washed four times with
PBS containing 0.1% Tween-20, the bands were devel-
oped with ECL detection reagent (Pierce). The same
amount protein of each sample was applied to a parallel
SDS-PAGE gel and stained with Coomassie brilliant blue.
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